2020
DOI: 10.1016/j.msec.2020.110756
|View full text |Cite
|
Sign up to set email alerts
|

Electrospun nanofibers for the delivery of active drugs through nasal, oral and vaginal mucosa: Current status and future perspectives

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
54
0
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 92 publications
(55 citation statements)
references
References 144 publications
0
54
0
1
Order By: Relevance
“…Recently, electrospinning has been considered as viable in the encapsulation of bioactive agents to improve their biocompatibility and bioaccessibility, including hydrophobic small substances, hydrophilic small substances and macromolecular active substances (e.g., enzymes, active proteins, probiotics) [ 86 ]. This technology has wide applications in filtration, wound dressing [ 87 ], drug delivery [ 88 ], tissue engineering [ 89 ], protective clothing, etc. However, there are manufacturing difficulties associated with the bioactive electrospun nanofibers.…”
Section: Electrospun Ultrafine Fibers For Reusable Face Masksmentioning
confidence: 99%
“…Recently, electrospinning has been considered as viable in the encapsulation of bioactive agents to improve their biocompatibility and bioaccessibility, including hydrophobic small substances, hydrophilic small substances and macromolecular active substances (e.g., enzymes, active proteins, probiotics) [ 86 ]. This technology has wide applications in filtration, wound dressing [ 87 ], drug delivery [ 88 ], tissue engineering [ 89 ], protective clothing, etc. However, there are manufacturing difficulties associated with the bioactive electrospun nanofibers.…”
Section: Electrospun Ultrafine Fibers For Reusable Face Masksmentioning
confidence: 99%
“…Besides, high drug loading ability, permeability and flexibility, exclusive surface topology, biomimetic properties, controllable morphology, distinct and abundant raw materials, suitable adhesion, and controlled mechanical properties also make these nanostructured materials quite interesting for drug-delivery applications. [1][2][3]10,[14][15][16][17][18][19] Polymeric nanofibers have been applied as DDS for delivery of antibiotic, [5,20] antimicrobial agents, [15,21] vitamins, [22] antiinflammatory, [23] analgesic, [2] antidepressant, [24] anticancer, [3] antimycotic [25] and anthelmintic, [14] as well as hormones. [8,10,17] Desirable release profile (ie, immediate, sustained, biphasic, or delayed) from drug-loaded polymeric nanofibers could be easily achieved by the choice of the polymer/solvent system and nanofiber fabrication method.…”
Section: Introductionmentioning
confidence: 99%
“…Drug delivery systems based on nanofibers have some advantages, including masking the taste of bitter drugs, a simple fabrication process, and superior pharmaceutical and pharmacokinetic performances when compared with regular delivery systems. Moreover, adhesive nanofibers have many characteristics, such as rapid dissolution, controlled release, and delayed action of drugs [ 159 ]. The drug release kinetics of nanofibers can be regulated by the selection of polymer, calixarene, cellulose, and other matrix materials, as well as the preparation process of nanofibers.…”
Section: Recent Advances and Future Prospectsmentioning
confidence: 99%